Phase 3 INSPIRE Study for EPP & XLP – Now Recruiting!
MT-7117 is a potential treatment for EPP and XLP. Recruiting patients ages 12+. International and US sites.
MT-7117 is a potential treatment for EPP and XLP. Recruiting patients ages 12+. International and US sites.